Shares of AirSculpt Technologies sank 10.5% to $3.07 as investors digested a second-quarter earnings miss and a jarring cut to the company's full-year profit outlook. For a premium body-contouring chain already trading near multi-year lows, the results sharpen a difficult question: is management investing for a turnaround or simply throwing money at a slowing business?
Revenue Slipped Again, and Fewer Patients Are Paying Full Price
AirSculpt posted Q2 revenue of $42.9 million, down 3% year over year, on case volume of 3,376 — a 0.5% decline.
Revenue per case fell to $12,707 from $12,975 a year earlier, meaning both volume and pricing moved in the wrong direction.
Management acknowledged that sales "saw moderating trends in June," blaming a "dynamic consumer environment."
That softness continued into July, with Q3 revenue expected to be down single digits.
The Profit Downgrade Is Bigger Than It Looks
Just one quarter ago, management reaffirmed adjusted EBITDA guidance — a measure of operating profit before certain charges — of $15–$17 million. Now that range has been slashed to $12–$14 million.
The company attributed the cut to "an intentional additional $5 million investment in marketing."
Customer acquisition cost jumped to roughly $3,500 per case from $2,900 a year ago — a 21% increase that has yet to produce measurable revenue growth. That math should worry shareholders.
Marketing Spend Is Rising, but Results Aren't Keeping Pace
AirSculpt faces new headwinds from AI-generated search results reducing click-through rates to its website, forcing costly changes to how it attracts patients online. Management framed the spending as offensive — broadening its procedures to target patients on GLP-1 weight-loss drugs who may want body sculpting. Gross margin did expand to about 61%, but that efficiency is being eaten by the ballooning marketing budget.
The Balance Sheet Buys Time, Not Comfort
Since early 2025, AirSculpt cut gross debt by $30 million to $44.2 million and grew cash by $10 million to $18.8 million.
It also raised roughly $20 million through an at-the-market stock offering this year — diluting existing shareholders — while paying down $13 million in debt. Liquidity is adequate for now, but if the consumer environment worsens, a company spending more while earning less has little margin for error.